A Seemingly Simple Question
Related Articles
Explore [UK NHS vs Private vs China: Real Cost of Three Options (2026)](https://mymedvia.com/medical-cost-comparison/uk-nhs-vs-private-vs-china-real-cost-of-three-options-2026/), [US vs China Medical Cost Comparison: From Outpatient to Inpatient (2026)](https://mymedvia.com/medical-cost-comparison/us-vs-china-medical-cost-comparison-from-outpatient-to-inpatient-2026/), and [Hidden Costs of Western Healthcare: The Bills You Didn’t See Coming (2026)](https://mymedvia.com/medical-cost-comparison/hidden-costs-of-western-healthcare-the-bills-you-didnt-see-coming-2026/).
“Why does a hip replacement cost $8,000 in China but $44,000 in the US?”
“The same CAR-T therapy: $500K in the US, $170K in China — how can there be a 3x difference?”
This is not a “you get what you pay for” situation. China’s top hospitals use the same surgical equipment, implants, and international standards — at 1/5 to 1/10 the price.
This article systematically explains why.
1. Core Reason: National Bulk Procurement
This is the single largest factor in China’s cost reduction.
What Is Bulk Procurement?
China’s government negotiates centrally with medical device manufacturers on behalf of all public hospitals. Massive guaranteed volume in exchange for the lowest possible price.
Results: Transformative Price Drops
| Device | Pre-Procurement | Post-Procurement | Reduction |
|---|---|---|---|
| Hip implant | ¥35,000 (~$4,800) | ¥7,000 (~$960) | 82% |
| Knee implant | ¥32,000 (~$4,400) | ¥5,000 (~$680) | 80%+ |
| Cardiac stent | ¥13,000 (~$1,800) | ¥700 (~$96) | 95% |
| IOL (cataract lens) | ¥5,000-¥8,000 | ¥1,000-¥2,000 | 70%-80% |
Cumulative patient savings since 2021: approximately ¥330 billion (~$45 billion).
Source: [China Daily HK, “Bulk procurement brings down medical costs”, Jan 2025](https://www.chinadailyhk.com/hk/article/601740)
2. Drug Price Differences: PD-1 Immunotherapy Example
| Drug | US Price (annual) | China Price (annual) | Difference |
|---|---|---|---|
| Pembrolizumab (Keytruda) | ~$170,000 | ~$30,000-$40,000 | 4-5x |
| Nivolumab (Opdivo) | ~$160,000 | ~$25,000-$35,000 | 4-6x |
| Tislelizumab (domestic PD-1) | Not available | ~$15,000-$20,000 | N/A |
| Sintilimab (domestic PD-1) | Not available | ~$10,000-$15,000 | N/A |
China’s domestic PD-1s offer non-inferior efficacy at a fraction of Keytruda/Opdivo prices.
Source: [The Lancet Oncology, Aug 2024](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00286-9/fulltext)
3. Operational Cost Differences
Labor Costs
| Role | US Annual Salary | China Annual Salary |
|---|---|---|
| Orthopedic surgeon | $400,000-$600,000 | $80,000-$150,000 |
| Registered nurse | $70,000-$100,000 | $15,000-$25,000 |
| Anesthesiologist | $350,000-$500,000 | $60,000-$120,000 |
China’s labor costs are roughly 1/5 to 1/4 of US levels — and these are high-income salaries in China.
Facility & Administration
US hospitals: admin costs at ~25% of revenue Chinese public hospitals: significantly lower administrative overhead US malpractice insurance/litigation: enormous cost, virtually nonexistent in China
4. Efficiency Through Surgical Volume
| Hospital | Annual Volume | Context |
|---|---|---|
| Beijing Jishuitan (orthopedics) | 40,000+ | ~10x UK’s largest center |
| Renji Hospital (endoscopy) | 260,000+ | #1 nationally, world’s largest |
| Fudan Shanghai Cancer Center | 60,000+ | 1.5M+ annual outpatients |
High volume → lower unit cost → greater surgeon proficiency → better outcomes → fewer complications → lower total cost.
This is a virtuous economic cycle.
5. Competitive Landscape
China’s medical market has three layers of competition:
Among public Grade 3A hospitals: Thousands compete, especially in top-tier cities International vs public international departments: Raffles, Jiahui vs PUMCH IMS, Friendship Intl Domestic vs imported products: Domestic PD-1s, joints, stents drive down import prices
Robust competition is the most effective price regulator.
6. Savings at a Glance
| Procedure | US ($) | China ($) | Savings |
|---|---|---|---|
| Hip Replacement | ~$44,000 | ~$8,000 | 82% |
| Knee Replacement | ~$30,000 | ~$6,800 | 77% |
| Cataract (both eyes) | $5,000-$10,000 | ~$2,500 | 50%-75% |
| Hernia Repair | $7,000-$15,000 | ~$3,000 | 60%-80% |
| Spinal Fusion | $50,000-$100,000 | ~$12,000 | 76%-88% |
| CAR-T Therapy | $373,000-$525,000 | ~$165,000 | 56%-68% |
| PET-CT | $3,000-$6,000 | ~$1,200 | 60%-80% |
| Gastroscopy | ~$2,700 | ~$800 | 70% |
| Acupuncture (10x) | $750-$1,900 | ~$800 | Up to 50% |
7. Does “Cheaper” Mean “Lower Quality”?
No. The most common misconception.
Beijing Jishuitan: RCSEd-accredited Shanghai Longhua: JCI-accredited Fudan Cancer Center: Nature Index Global Top 100 China surpassed the US in CAR-T clinical trials in 2024
Why low cost + high quality coexist:
Structural cost differences, not quality differences:
Same Da Vinci robots, linear accelerators — lower per-use allocation due to higher volume Same implants — bulk procurement price is 10%-20% of US hospital purchase price Same drugs — China’s regulated pricing vs US free-market pricing
8. Conclusion
China’s lower costs are not “downgrades” — they result from:
National bargaining power (bulk procurement) Structural cost advantages (labor, administration) High efficiency and scale (surgical volume) Robust competition (international, domestic, public, private)
For US patients: 50%-90% savings. For UK patients: skip NHS queues without paying UK private prices.
Contact mymedvia through our website. Tell us your medical needs. We’ll provide a clear cost estimate.
mymedvia — High-quality care at a fraction of the cost.
